Current status on M. pneumoniae: Clinical Features and Management Strategies
Background: The COVID-19 pandemic has significantly impacted Mycoplasma pneumoniae (MP), leading to a decline in prevalence and delayed resurgence. The rise of macrolide-resistant M. pneumoniae complicates treatment, necessitating alternative antibiotics. Aim: This review examines the impact of...
Saved in:
| Main Authors: | Asit K, Bragadeeshwaran N, Janhavi MS, Shamina S, Lavanya SV, Suria P, Muthu PP |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nigerian Medical Association, Akwa Ibom State Branch
2025-04-01
|
| Series: | Ibom Medical Journal |
| Subjects: | |
| Online Access: | http://ibommedicaljournal.org/index.php/imjhome/article/view/684 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of community-acquired pneumonia using the modern therapeutical guides
by: Škodrić-Trifunović Vesna, et al.
Published: (2006-01-01) -
Concerning the Diagnostic and Treatment Problems of Children with Pneumonia
by: M. D. Bakradze, et al.
Published: (2015-10-01) -
Assessment of current laboratory diagnosis of pneumococcal community-acquired pneumonia
by: Е. A. Koshkarina, et al.
Published: (2020-12-01) -
Role of BioCard Mycoplasma Immunoglobulin M Rapid Test in the Diagnosis of Mycoplasma pneumoniae Infection
by: Ta-Yu Liu, et al.
Published: (2018-01-01) -
Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)